Healthcare providers in the US are at odds with commercial insurance payers over a rising tide of prior authorization and claim payment denials from Medicare Advantage (MA) plans. Even as they gain popularity, providers are reconsidering their relationships with MA due to the tremendous operational and financial strain of doing business with them.
Our new brief contains data insights and recommendations that can help you develop strategies to mitigate the impact of MA denials on cash flow and revenue.
Key takeaways include: